Cellular targets and molecular activity mechanisms of bee venom in cancer: recent trends and developments
dc.authorid | Ali Zarrabi / 0000-0003-0391-1769 | en_US |
dc.authorscopusid | Ali Zarrabi / 23483174100 | |
dc.authorwosid | Ali Zarrabi / U-2602-2019 | en_US |
dc.contributor.author | Varol, Ayşegül | |
dc.contributor.author | Sezen, Serap | |
dc.contributor.author | Evcimen, Dilhan | |
dc.contributor.author | Zarepour, Atefeh | |
dc.contributor.author | Ulus, Gönül | |
dc.contributor.author | Zarrabi, Ali | |
dc.contributor.author | Badr, Gamal | |
dc.contributor.author | Dastan, Sevgi Durna | |
dc.contributor.author | Orbayoglu, Asya Gulistan | |
dc.date.accessioned | 2022-03-09T09:08:00Z | |
dc.date.available | 2022-03-09T09:08:00Z | |
dc.date.issued | 2022 | en_US |
dc.department | İstinye Üniversitesi, Mühendislik ve Doğa Bilimleri Fakültesi, Biyomedikal Mühendisliği Bölümü | en_US |
dc.description.abstract | Bee venom therapy is known as a traditional approach to curing many medical conditions such as arthritis, pain and rheumatism. Bee venom also provides promising potential for treating many cancers such as breast, lung, ovary, stomach, kidney, prostate, cervical, colon and esophageal cancers, osteosarcoma, leukemia, melanoma and hepatocellular carcinoma. We therefore focused not only on the molecular activity mechanisms and cellular targets of bee venom and its components, but also on modern solutions as cutting-edge nanotechnological advances to overcome existing bottlenecks, and the latest advances in the anticancer application of bee venom in clinical settings. | en_US |
dc.identifier.citation | Varol, A., Sezen, S., Evcimen, D., Zarepour, A., Ulus, G., Zarrabi, A., Badr, G., Daştan, S.D., Orbayoğlu, A.G., Selamoğlu, Z., Varol, M., 2022. Cellular targets and molecular activity mechanisms of bee venom in cancer: recent trends and developments. Toxin Reviews 1–14. | en_US |
dc.identifier.doi | 10.1080/15569543.2021.2024576 | en_US |
dc.identifier.issn | 1556-9551 | en_US |
dc.identifier.issn | 1556-9543 | en_US |
dc.identifier.scopus | 2-s2.0-85125340070 | en_US |
dc.identifier.scopusquality | Q3 | en_US |
dc.identifier.uri | https://doi.org/10.1080/15569543.2021.2024576 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12713/2533 | |
dc.identifier.wos | WOS:000756197300001 | en_US |
dc.identifier.wosquality | Q2 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | TOXIN REVIEWS | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Apitherapy | en_US |
dc.subject | Anti-inflammatory Drugs | en_US |
dc.subject | Bee Venom | en_US |
dc.subject | Cancer | en_US |
dc.subject | Melittin | en_US |
dc.title | Cellular targets and molecular activity mechanisms of bee venom in cancer: recent trends and developments | en_US |
dc.type | Article | en_US |
Dosyalar
Orijinal paket
1 - 1 / 1
Küçük Resim Yok
- İsim:
- Varol-2022-Cellular-targets-and-molecular-acti.pdf
- Boyut:
- 2.21 MB
- Biçim:
- Adobe Portable Document Format
- Açıklama:
- Tam Metin / Full Text
Lisans paketi
1 - 1 / 1
Küçük Resim Yok
- İsim:
- license.txt
- Boyut:
- 1.44 KB
- Biçim:
- Item-specific license agreed upon to submission
- Açıklama: